Group 1 - The core point of the article is that Rhine Biology (002166.SZ) is undergoing significant changes in its ownership structure and is planning to acquire a majority stake in Beijing Jinkangpu Food Technology Co., Ltd. [1] - The controlling shareholder, Qin Benjun, intends to transfer 60 million shares (8.09% of total share capital) to Guangzhou Defu Nutrition and will relinquish voting rights for 189,141,310 shares (25.50% of total share capital), retaining only 3.00% voting rights [1] - Following this transfer, Guangzhou Defu Nutrition will become the controlling shareholder, with Hou Ming and Li Zhenfu as the joint actual controllers of the company [1] Group 2 - The target company specializes in the formulation, production, testing, sales, technological innovation, and services of food nutrition fortifiers, which are widely used in dairy products, functional beverages, complementary foods, medical foods, and health foods [2] - The target company is a leading enterprise in the food nutrition fortifier sector, supplying nutrition fortifiers to numerous infant formula manufacturers both domestically and internationally [2] - This acquisition will allow the listed company to expand its industrial chain into the nutrition fortifier compounding field, creating a closed-loop from upstream raw materials to downstream formulation solutions, enhancing business synergy and stability [2]
莱茵生物(002166.SZ):控股股东拟将变更为广州德福营养 股票明起复牌